Anti-perforin neutralizing antibody reduces myocardial injury in viral myocarditis

Cardiology in the Young

Volumn 19, Issue 6, 2009, Pages 601-607

  Chun Yan, Guo ^a   Bo, Han ^a   Hong, Chang ^b   Hong Lei, Jiang ^a   Xiu Zhen, Han ^a  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Cytotoxic T lymphocytes; Mice

Indexed keywords

CASPASE 3; MESSENGER RNA; NEUTRALIZING ANTIBODY; PERFORIN NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DRUG EFFICACY; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS MYOCARDITIS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES; APOPTOSIS; CASPASE 3; COXSACKIEVIRUS INFECTIONS; DOWN-REGULATION; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; PERFORIN; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 76349099139     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S104795110999182X     Document Type: Article

References (27)

1. Podack ER. Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr Opin Immunol 1995; 7: 11-16.
2. Hassin D, Fixler R, Shimoni Y, et al. Physiological changes induced in cardiac myocytes by cytotoxic T lymphocytes. Am J Physiol 1987; 252: C10-C16.
3. Jerome KR, Sloan DD, Aubert M. Measurement of CTL-induced cytotoxicity: the caspase 3 assay. Apoptosis 2003; 8: 563-571.
4. Zhang F, Chu X, Wang L, et al. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 2006; 76: 427-431.
5. Seko Y, Shinkai Y, Kawasaki A. Evidence of perforin-mediated cardiac myocardiac myocyte injury in acute murine myocarditis caused by coxsackievirus B3. J Pathol 1993; 170: 53-58.
6. Gupta M, Greer P, Mahanty S, et al. CD8-mediated protection against Ebola virus infection is perforin dependent. Immunology 2005; 174: 4198-4202.
7. Xiong DD, Yang YZ, Hu Y, Chen HZ. The relationship between the dynamic changes of Perforin expression level and myocardiac lesion in experimental viral myocarditis. Chinese Journal of Cardiology 1998; 26: 21-23.
8. Xiong D, Yang Y, Hu Y, Chen H. The role of cytotoxisity effecter mediated by Perforin in mice with viral myocarditis. Journal of Shanghai Medical University 1999; 26: 128-130.
9. White MK, Amini S, Khalili K, Kogan M, Donaldson K, Darbinian N. Development of a bidirectional caspase-3 expression system for the induction of apoptosis. Cancer Biol Ther 2008; 7: 945-954.
10. Gobe G. Identification of apoptosis in kidney tissue sections. Methods Mol Biol 2009; 466: 175-192.
11. Lee SH, Bar-Haim E, Machlenkin A, et al. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Cancer Gene Ther 2004; 11: 237-248.
12. Cunningham TD, Jiang X, Shapiro DJ. Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity. Cell Immunol 2007; 245: 32-41.
13. Kim JH, Kang TH, Noh KH, et al. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD81 T cell-mediated cell death. Immunol Lett 2009; 122: 58-67.
14. Voskoboinik I, Thia MC, Fletcher J, et al. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: A critical role for aspartate residues 429, 435, 483, and 485 but not 491. J Biol Chem 2005; 280: 8426-8434.
15. Liu CC, Walsh CM, Young JD. Perforin: structure and function. Immunol Today 1995; 16: 194-201.
16. Sauer H, Pratsch L, Tschopp J, Bhakdi S, Peters R. Functional size of complement and perforin pores compared by confocal laser scanning microscopy and fluorescence microphotolysis. Biochim Biophys Acta 1991; 1063: 137-146.
17. Zorc-Pleskovic R, Alibegović A, Zorc M, Milutinović A, Radovanović N, Petrović D. Apoptosis of cardiomyocytes in myocarditis. Folia Biol (Praha) 2006; 52: 6-9.
18. DeBiasi RL, Robinson BA, Sherry B, et al. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol 2004; 78: 11040-11050.
19. Kyto V, Saraste A, Saukko P, et al. Apoptotic cardiomyocyte death in fatal myocarditis. Am J Cardiol 2004; 94: 746-750.
20. Saraste A, Arola A, Vuorinen T, et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol 2003; 12: 255-262.
21. Cooper DM, Granville DJ, Lowenberger C. The insect caspases. Apoptosis 2009; 14: 247-256.
22. Fujikawa DG, Shinmei SS, Zhao S, Aviles ER Jr. Caspasedependent programmed cell death pathways are not activated in generalized seizure-induced neuronal death. Brain Res 2007; 1135: 206-218.
23. Zhang YB, Ye YP, Wu XD, Sun HX. Astilbotriterpenic acid induces growth arrest and apoptosis in HeLa cells through mitochondria-related pathways and reactive oxygen species (ROS) production. Chem Biodivers 2009; 6: 218-230.
24. Ghosh S, Khazaei M, Moien Afshari F, et al. Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice. Am J Physiol Renal Physiol 2009; 14.
25. Purevjav E, Nelson DP, Varela JJ, et al. Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy. Cardiovasc Toxicol 2007; 7: 255-263.
26. Zapata JM, Takahashi R, Salvesen GS, Reed JC. Granzyme release and caspase activation in activated human T-lymphocytes. Biol Chem 1998; 273: 6916-6920.
27. Galvin JP, Spaeny-Dekking LH, Wang B, Seth P, Hack CE, Froelich CJ. Apoptosis induced by granzyme B-glycosaminoglycan complexes: implications for granule-mediated apoptosis in vivo. Immunol 1999; 162: 5345-5350.